Kenneth C. Cundy, SVP, Preclinical Development at XENOPORT INC (XNPT), sold 2,000 shares at $18.46 ($37K) on 2010-02-01, disclosed to the SEC on 2010-02-04.
Scheduled sale ($37k) by SVP, Preclinical Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.30 | 100 | $2K | 4.9% |
| 2 | $18.32 | 100 | $2K | 4.9% |
| 3 | $18.36 | 200 | $4K | 9.9% |
| 4 | $18.39 | 100 | $2K | 5.0% |
| 5 | $18.43 | 100 | $2K | 5.0% |
| 6 | $18.46 | 100 |
| $2K |
| 5.0% |
| 7 | $18.47 | 100 | $2K | 5.0% |
| 8 | $18.49 | 200 | $4K | 10.0% |
| 9 | $18.50 | 100 | $2K | 5.0% |
| 10 | $18.52 | 100 | $2K | 5.0% |
| 11 | $18.57 | 100 | $2K | 5.0% |
| 12 | $18.58 | 100 | $2K | 5.0% |
| 13 | $18.60 | 200 | $4K | 10.0% |
| 14 | $18.61 | 100 | $2K | 5.0% |
| 15 | $18.68 | 100 | $2K | 5.0% |
| 16 | $18.72 | 100 | $2K | 5.1% |
| 17 | $18.79 | 30 | $564 | 1.5% |
| 18 | $18.80 | 2 | $38 | 0.1% |
| 19 | $18.81 | 68 | $1K | 3.5% |
| Total | $18.51 avg | 2,000 | $37K | 100% |
| Filing → |
| CWBR | SELL | 2020-08-10 | $19K | — | Filing → |
| CWBR | SELL | 2020-06-17 | $24K | — | Filing → |
| CWBR | SELL | 2020-05-18 | $26K | — | Filing → |